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Abstract
Background: We established a male, multiethnic cohort primarily to study prostate cancer
etiology and secondarily to study the etiologies of other cancer and non-cancer conditions.
Methods/Design: Eligible participants were 45-to-69 year old males who were members of a
large, prepaid health plan in California. Participants completed two surveys on-line or on paper in
2002 – 2003. Survey content included demographics; family, medical, and cancer screening history;
sexuality and sexual development; lifestyle (diet, physical activity, and smoking); prescription and
non-prescription drugs; and herbal supplements. We linked study data with clinical data, including
laboratory, hospitalization, and cancer data, from electronic health plan files.
We recruited 84,170 participants, approximately 40% from minority populations and over 5,000
who identified themselves as other than heterosexual. We observed a wide range of education
(53% completed less than college) and income. PSA testing rates (75% overall) were highest among
black participants. Body mass index (BMI) (median 27.2) was highest for blacks and Latinos and
lowest for Asians, and showed 80.6% agreement with BMI from clinical data sources. The sensitivity
and specificity can be assessed by comparing self-reported data, such as PSA testing, diabetes, and
history of cancer, to health plan data. We anticipate that nearly 1,500 prostate cancer diagnoses
will occur within five years of cohort inception.
Discussion: A wide variety of epidemiologic, health services, and outcomes research utilizing a
rich array of electronic, biological, and clinical resources is possible within this multiethnic cohort.
The California Men's Health Study and other cohorts nested within comprehensive health delivery
systems can make important contributions in the area of men's health.
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Background
In 2002 – 2003, we established the California Men's
Health Study (CMHS), a multiethnic cohort of 84 170
men ages 45 to 69 years who are members of the northern
and southern California regions of Kaiser Permanente, the
largest managed care organization in California. The
major goal of the study is to improve understanding of the
development of prostate cancer due to the huge impact it
exerts on morbidity and mortality of American males,
especially African-American males [1]. By establishing the
cohort within an integrated managed care organization,
we have access to rich electronic data sources to supple-
ment clinical data collected by survey and to permit the
identification and investigation of other health outcomes
including other cancers and other non-cancerous condi-
tions.
We obtained baseline data from the men using a two-stage
mailed survey, and we employed unique recruitment tech-
niques to enrich the cohort with non-white men. With
this cohort, we plan to build on previous work and inves-
tigate novel hypotheses in the broad area of men's health.
This paper is to describe the baseline demographic charac-
teristics, health status, and lifestyle behaviors of the
cohort, to estimate expected cases of cancer, to evaluate
the validity of the self-reported data, and to examine how
representative the cohort was to the larger population.
Methods/design
Participant eligibility criteria and identification
Eligible participants included all male California Kaiser
Permanente (KP) Health Plan members, aged 45 to 69
years in January 2000, who had been members of the
health plan for at least one year at recruitment. We identi-
fied potential participants from electronic KP member-
ship files containing each member's birthdate, current
address, and membership history. At recruitment, nearly
850,000 health plan members met the eligibility criteria.
The study protocol was reviewed and approved for the
protection of human subjects by the Institutional Review
Boards of Kaiser Permanente Northern California and
Kaiser Permanente Southern California.
Participant recruitment and data collection
We recruited participants beginning in January 2002 and
concluding at the end of December 2003 using a two-step
process in three mailing waves. In the first step of each
mailing wave, we mailed a recruitment letter and a short
questionnaire in English/Cantonese to potentially eligible
health plan members with Chinese surnames [2,3] or in
English/Spanish to all other potentially eligible members.
The short questionnaire requested information on the
men's race/ethnicity, information not routinely collected
by the health plan. In the second step of each mailing
wave, we mailed a cover letter and a longer, comprehen-
sive questionnaire to participants who had completed and
returned the short questionnaire. The cover letter and
questionnaire were in the language in which the partici-
pant completed the short questionnaire, and the cover let-
ters accompanying the questionnaires were tailored to the
participant's specific race/ethnic group and were signed by
a well known athletic (black/African-American) or politi-
cal (Latino) figure or by one of the study investigators (all
others). Members were also offered the option to com-
plete the questionnaires electronically in English on a
secure website (NCS Pearson, Inc.).
Recruitment mailings were done in three waves using
mailing strategies to enhance recruitment of minority
male members. In mailing wave one, we mailed to mem-
bers residing near KP medical centers serving the highest
estimated proportion of African-American men and to
members we identified with Chinese [2,3] Spanish sur-
names [4]. In mailing wave two, we mailed to men either
who were listed as minority based on hospitalization
information or who resided near additional KP facilities
with high minority populations. In mailing wave three,
due to limited study funds, remaining potentially eligible
members were mailed a recruitment letter inviting them
to complete both questionnaires on the website, and they
had the option of requesting a paper questionnaire. Mail-
ing waves included 200,000 to 350,000 members.
Questionnaires
The short (2-page) questionnaire included questions on
race/ethnicity, anthropometrics, prostate specific antigen
(PSA) testing history and personal history of prostate can-
cer or benign prostatic hyperplasia (BPH).
The longer (24-page) questionnaire solicited information
on demographics, family history of cancer, health and
lifestyle, prostate-related symptoms and conditions, other
existing health conditions, medication/drug use, physical
activity, tobacco use, diet/supplement use, country of ori-
gin, duration of U.S. residency, income, and sexual devel-
opment, orientation, and health. Lower urinary tract
symptoms were assessed using the American Urology
Association Symptom Index (AUASI) [5], while erectile
dysfunction was assessed by a four-level single question
adapted form the Massachusetts Male Aging Study [6]. We
assessed diet with a detailed semi-quantitative food-fre-
quency questionnaire adapted from a questionnaire
developed for the Women's Health Initiative and other
studies [7-9], modified to men's studies of prostate health
[10]. We assessed physical activity with questions adapted
from the CARDIA Physical Activity History [11-13] that
queried the men about the frequency and duration of
their participation in specific types of moderate and vigor-
ous recreational, household, and work-related activities.BMC Public Health 2006, 6:172 http://www.biomedcentral.com/1471-2458/6/172
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The CARDIA questionnaire has indirect validity against
aerobic capacity and percent body fat [11,12] and a strong
inverse relation with most cardiovascular disease risk fac-
tors [14,15].
We manually reviewed paper questionnaires for stray
marks, completeness, and multiple responses. We opti-
cally scanned the questionnaires into study computers
using ScanTools® II Software (Pearson NCS, Inc, Bloom-
ington, MN). We uploaded the data into SAS data man-
agement databases (SAS Statistical Software Version 8.2,
SAS Statistical Institute, Cary, NC) for cleaning and stor-
age. We used computerized edits to assess the data for
logic errors, out-of-range values, missing data, and multi-
ple responses.
Analytical/statistical methods
We constructed the variables reported in the tables from
both self-reported and health plan data. We linked study
databases with electronic health plan databases using the
member's health record number, a unique subject identi-
fier. The health plan data provided information about the
participants' KP membership history, hospitalization his-
tory, laboratory results, and other health conditions
including cancer and diabetes. We used health plan data
to validate specific survey data items when comparable
health plan data existed.
We created new variables and categorical variables from
the raw questionnaire data. Body mass index (BMI), a
measure of obesity, was calculated as weight (kilograms)
divided by the square of height (meters2). Participants
who did not complete all pages of the food frequency
questionnaire (at least five items per page) or who had
total calculated energy intake below (less than 800 kcal)
or above (greater than 5,000 kcal) what we considered
reasonable were excluded from the nutrient analyses. Rec-
reational physical activity summary scores were derived
by multiplying assigned MET values13 by duration and fre-
quency and summing across activities. We defined vigor-
ous activities as participating in a minimum of 1,260
MET-hours per week, on average, equivalent to at least 3.5
hours of activity with a minimum MET level of 6. We
defined moderate and vigorous activities combined as
participating in a minimum of 630 MET-hours of activity
per week, on average, equivalent to at least 3.5 hours of
activity with a minimum MET level of 3.
We determined the expected number of cases of prostate,
colorectal, lung, and bladder cancer and melanoma based
on the expected baseline age distribution of the cohort of
84,170 men, and the age and race/ethnic specific annual
(average 1992–1996) cancer incidence rates for the State
of California. We account for an assumed 4% annual rate
of loss to follow-up, due to mortality and loss to follow-
up, based on our experience with other cohort studies.
We calculated percent agreement between BMI derived
from self-reported weight and height and BMI from clini-
cal databases. We cross tabulated the data grouped accord-
ing to BMI categories of normal weight (<25), overweight
(25–29), and obese (30 or higher), and then calculated
the percent agreement as the total number of participants
for whom BMI was classified in the same category by both
sources divided by the total number of participants with
clinical BMI data available.
Cohort characteristics
Response rates varied across mailing strategies (Table 1).
Short questionnaire responses were substantially higher
Table 1: Recruitment figures: CMHS Cohort, California.
Mailing Wave Total number Recruited Number of responses Response %
1 and 2 (paper with electronic option1)
Short questionnaire 503 237 114 953 22.8
Long questionnaire 114 953 67 413 58.6
3 (electronic with paper option2)
Short questionnaire 345 262 19 107 5.4
Long questionnaire 19 107 16 757 87.7
Total – 1, 2 and 3
Short questionnaire 848 499 134 060 15.8
Paper 103 383
Electronic 30 677
Long questionnaire 134 060 84 170 62.8
Paper 57 204
Electronic 26 966
1 Participants were mailed paper questionnaires but given the option to complete the questionnaires on a secure website
2 Participants were invited to complete the questionnaires on a secure website but offered the option to request a paper questionnaireBMC Public Health 2006, 6:172 http://www.biomedcentral.com/1471-2458/6/172
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when we mailed questionnaires (waves one and two)
than when we invited the men to complete the question-
naire on-line (wave three). Conversely, among those who
completed the short questionnaire, the responses to the
long questionnaire were 50% higher among men
recruited in wave three compared to men recruited in
waves one and two. Overall, the participants completed
nearly one-quarter of the short questionnaires and nearly
one-third of the long questionnaires on the secure web-
site.
A total of 84170 men joined the cohort, and nearly 40%
were minority (Table 2). Participants were distributed
fairly evenly across age groups, although Latino, Asian,
and 'other/mixed race/ethnicity' men tended to be some-
what younger, a reflection of the general KP membership
age distribution. Educational attainment varied by race/
ethnicity, with over half of whites and Asians having
earned at least a college degree compared to one-third of
black participants and over one-fifth of Latinos. Income
distributions also varied by race/ethnicity, with white par-
ticipants reporting the highest and Latinos reporting the
lowest incomes.
One in five participants had a history of BPH, a benign but
frequently symptomatic prostate enlargement (Table 3).
Rates among white men were the highest and were more
than 50% higher than those of Asian men who experi-
enced the lowest rates. A history of prostatitis, a painful
inflammation of the prostate usually due to infection, was
also most common among white participants and more
than twice as common as among Asians. Nearly half
(48.6%) of the cohort reported moderate or severe LUTS,
while 29.9% of the men reporting sometimes or never
being able to get or keep an erection (e.g., erectile dysfunc-
tion).
Most participants reported having received PSA testing
sometime in the past (Table 3). Black participants were
most likely and Latino participants were least likely to
have reported receiving a test. We observed only slight
race/ethnic variation in the percentage of participants
who received fasting glucose, HDL cholesterol, choles-
terol panel, or triglyceride laboratory tests within the five
years before cohort enrollment. In general, however,
Asian participants were most likely and Latino partici-
pants were least likely to have received the tests.
We observed that energy and nutrient intakes varied
somewhat by race/ethnicity (Table 4). Asian participants
reported the lowest consumption of calories and percent
calories from fat, fiber, protein and alcohol. Conversely,
white participants reported the highest consumption of
calories, fiber, and alcohol. Fruit consumption (servings)
was similar across race/ethnic groups.
Table 2: Distribution of participants by age, educational attainment, and current household income, by race/ethnicity: CMHS Cohort, 
California.
Race/Ethnicity (%)
White
N = 51 746
Black/African
American
N = 6302
Latino
N = 11 428
Asian
N = 6400
Other/mixed
N = 7459
Missing
N = 835
Total
N = 84 170
Age (years)
45–49 13.7 14.9 22.3 17.9 19.0 16.0 15.7
50–54 19.1 18.8 22.2 22.9 20.9 17.8 20.0
55–59 23.0 20.5 19.3 18.4 21.4 19.1 21.8
60–64 22.3 23.0 18.1 18.8 20.8 21.1 21.4
65–69 21.6 22.6 17.8 21.8 17.7 25.7 20.9
Educational Attainment
Less than high school 2.6 5.7 24.4 6.5 4.4 9.0 6.3
HS grad or GED 10.7 16.3 18.5 9.6 11.7 16.7 12.2
Vocational/tech school 4.0 5.0 7.9 5.1 5.3 6.9 4.8
Some college/AA 29.7 39.8 27.7 20.3 32.6 31.3 29.8
College graduate 22.1 16.4 10.1 28.5 26.0 16.4 20.8
Grad/prof school 30.6 16.5 10.9 29.7 19.8 19.4 25.8
Current household income ($)
Less than 20,000 3.3 6.2 10.9 6.3 5.5 8.5 5.0
20 000 – 39 999 12.6 18.7 27.8 15.5 17.0 22.7 15.8
40 000 – 59 999 18.2 21.9 22.5 19.2 20.7 21.8 19.4
60 000 – 79 999 18.7 19.9 17.2 16.8 19.6 19.0 18.5
80 000 – 99 999 14.7 13.4 9.5 14.2 13.5 10.5 13.7
100 000 or more 32.1 19.5 11.8 27.7 23.4 17.3 27.2BMC Public Health 2006, 6:172 http://www.biomedcentral.com/1471-2458/6/172
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The median BMI for the cohort was high with more than
50% of participants considered overweight (Table 4).
Blacks and Latinos had the highest and Asians had the
lowest median BMI. Nearly two-thirds of participants
reported regular moderate or vigorous recreational activi-
ties and over 40% reported regular vigorous recreational
activities, with the highest rates among white participants.
Although smoking rates were low overall, rates among
black participants, the highest, were more than double the
rates of Asian participants, the lowest.
Over 5,000 participants identified themselves as other
than heterosexual, with the highest proportion among
white and the lowest proportion among Asian partici-
pants (Table 4).
Table 4: Mean daily energy and nutrient intakes, median body size, percentage of participation in moderate and vigorous physical 
activities, current smoking status, and sexual orientation, by race/ethnicity, based on self-reported survey data: CMHS Cohort, 
California.
Race/Ethnicity
White Black/African American Latino Asian Other Total
Dietary factors
Calories 2218.3 2024.5 2037.1 1765.0 2088.6 2139.0
%  c a l o r i e s  f r o m  f a t 3 4 . 8 3 5 . 5 3 4 . 83 2 . 83 4 . 63 4 . 7
Dietary fiber (gm) 22.3 18.3 21.5 17.2 20.1 21.4
Protein (gm) 95.9 87.1 88.8 84.1 93.0 93.3
Fruit (servings) 2.2 2.3 2.3 2.2 2.3 2.2
Vegetables (servings) 2.2 1.9 1.9 1.7 2.1 2.1
Alcohol (gm) 13.4 8.6 9.1 4.4 8.9 11.5
BMI (median) 27.2 28.2 28.2 24.7 26.7 27.2
Physical activity (%)
Moderate/vigorous2 65.7 49.2 52.9 57.7 57.2 61.2
Vigorous3 46.6 33.5 36.2 37.4 39.1 42.8
Current smoker (%) 9.5 17.0 14.4 8.2 11.8 10.8
Sexual Orientation (%)
Heterosexual 93.7 95.4 94.4 94.5 90.9 93.7
Homosexual 4.4 1.8 2.2 1.2 3.0 3.5
Bisexual 1.3 1.1 1.2 1.5 1.9 1.3
Other 0.5 1.5 2.1 2.6 4.0 1.2
1 moderate or vigorous activity defined as a minimum of 630 MET-hours activity per week on average, equivalent to at least 3.5 hours of activity 
with MET level minimum of 3.
2 vigorous activity defined as a minimum of 1260 MET-hours activity per week on average, equivalent to at least 3.5 hours of activity with MET level 
minimum of 6.
Table 3: Distribution of specific prostate conditions and laboratory tests, by race/ethnicity: CMHS Cohort, California.
Race/ethnicity (%)
White Black/African-American Latino Asian Other Total
Prostate diagnoses and procedures1
BPH diagnosis 22.9 21.5 17.5 13.8 16.7 20.8
Prostatitis diagnosis 7.6 6.2 5.5 3.4 5.1 6.6
Laboratory tests2
PSA 75.5 83.8 67.9 72.9 71.0 74.5
Fasting glucose 59.0 63.4 57.2 65.0 64.0 60.0
HDL cholesterol 55.0 50.5 45.8 66.1 58.1 54.5
Cholesterol panel 80.7 82.4 77.1 86.3 82.6 80.9
Triglycerides 68.0 66.8 63.6 71.3 70.3 67.8
1 Prostate diagnoses and procedures were obtained from survey data where participants reported having ever been diagnosed with BPH or 
prostatitis
2 Laboratory test data were obtained from electronic health plan databases and included tests done during the five-year period before cohort 
enrollmentBMC Public Health 2006, 6:172 http://www.biomedcentral.com/1471-2458/6/172
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We anticipate that nearly 1,500 prostate cancer diagnoses
will occur among participants during the 5 years after
cohort inception (Table 5). We also anticipate sufficient
diagnoses of lung and colorectal cancers, and other dis-
eases of similar incidence, within 5 years to conduct well
powered analyses of etiological factors. There may also be
sufficient bladder cancer and melanoma diagnoses to con-
duct basic etiological analyses.
In addition to cancer outcomes, a significant number of
newly diagnosed cases of cardiovascular diseases and neu-
rodegenerative diseases are expected. Based on estimates
in the literature, estimates of the expected number of new
cases in the CMHS participants after five years of follow-
up (and adjusting for loss of follow-up and mortality)
include: 5,000 new cases of myocardial infarction, 5,100
cases of congestive heart failure, 180 cases of Parkinson's
disease, 7,000 cases of dementia, and 370 cases of Alzhe-
imer's disease.
We compared CMHS participants with male participants
in the California Health Interview Survey (CHIS), a popu-
lation-based telephone survey of 55,000 California resi-
dents in 2001 [16] (Table 6). Distributions of participants
were similar for the demographic factors examined as well
as for BMI. Substantially more CMHS participants had
reported at least one PSA test than CHIS participants,
probably due to complete insurance coverage among
CMHS participants.
We also performed a small comparison of CMHS partici-
pants to non-participants of the same age range. A total of
84.4% CMHS participants were KP members for at least
five years compared to 75.3% of non-participants. The
percentage hospitalized during the 5 years before recruit-
ment were similar for the two groups (17.0% of partici-
pants versus 15.6% of non-participants), and the
prevalence of diabetes mellitus was nearly identical
(13.5% for participants versus 13.6% for non-partici-
pants).
We validated BMI calculated from self-reported weight
and height in relation to BMI reported in health plan clin-
ical databases (Table 7). Overall, the percentage of partic-
ipants who were classified into the same BMI categories by
both sources was over 80%, and the percent of partici-
pants who were classified into the same or adjacent cate-
gories was 99.4%.
Discussion
We assembled a large, multiethnic male cohort from the
membership of the largest managed care organization in
California to study prostate cancer etiology and the etiol-
ogies of other cancer and non-cancerous conditions.
CMHS participants are diverse in socioeconomic status as
well as race/ethnicity, where both ends of the income and
education spectrum are well represented in the cohort.
The managed care setting is ideal to study disease risk fac-
tors and health services delivery where health care access
issues are minimized and supplemental data sources are
maximized and can be used to verify and extend the ques-
tionnaire data.
The availability of supplemental electronic data is a
unique and important strength of this cohort. For exam-
ple, we can conduct electronic data linkages between
cohort and electronic health plan files to obtain current
and historical data, obtain information on outcomes
other than cancer, and conduct validation studies of self-
reported data. Electronic data sources can be used to fol-
low the participants for updated contact information
from membership files, cancer diagnoses through cancer
registry databases, and deaths of through linkage with
health plan mortality databases derived from state death
certificate files.
Another advantage of these data within this setting is the
ability to assess the sensitivity and specificity of the self-
reported data on health conditions and PSA testing by
comparing these data to clinical databases of the health
plan. The BMI from self-report was in high agreement
with clinical BMI data, suggesting that data collection by
self-report was reliable. However, a limitation of these
analyses is the inability to identify diagnoses that pre-
dated the participant's health plan membership or the
inception date of the electronic database.
Table 5: Expected number of cancer diagnoses by December 31, 2006: CMHS Cohort, California.
Cancer Site
Prostate Colorectum Lung Skin: Melanoma Bladder
White 933 284 449 133 183
Black/African American 203 46 85 1 11
Latino 131 43 41 4 13
Asian/Pacific Islander 77 45 51 1 11
Other 116 26 23 24 18
Total 1460 444 648 162 237BMC Public Health 2006, 6:172 http://www.biomedcentral.com/1471-2458/6/172
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Another unique strength of this cohort is the potential to
conduct efficient biospecimen-based research studies. The
health plan maintains tissue banks of tumor and non-
tumor tissue blocks, some from as early at the 1950s, and
the health plan manages a system of clinical laboratories
that can be used for the efficient collection of blood spec-
imens. The availability of these resources greatly facilitates
research of genetic markers and other molecular studies.
Prospective cohort studies are considered the gold stand-
ard of epidemiologic research because many biases that
can hamper interpretation of case-control studies are, by
design, minimized in prospective cohort studies [17,18].
Cohort studies also facilitate the study of multiple out-
comes, unlike other observational study designs. A draw-
back to cohort studies is the long follow-up time often
required to obtain sufficient power to conduct statistical
analyses, typically low recruitment rates, and loss to fol-
low-up that can harm internal validity. However, we
anticipate having sufficient statistical power within five
years of cohort inception to conduct prostate cancer anal-
yses. Our cost-saving strategies of not re-contacting men
who did not respond initially and of mailing the long
questionnaire only to men who completed the 2-page
questionnaire enhanced the likelihood of obtaining favo-
rable follow-up rates and therefore high internal study
validity, because the final cohort included only the men
who were willing to complete two questionnaires sepa-
rated in time.
Table 7: Percent agreement between BMI calculated from self-reported weight and height and from electronic clinical databases: 
CMHS Cohort1, California.
Self-Reported BMI2
BMI from clinical databases2 <25 25–29 30+ Total
<25 3059 596 34 3689
25–29 1078 6652 487 8217
30+ 94 1424 5669 7187
Total 4231 8672 6190 19 093
% Agreement 80.6%
1 BMI validation includes only participants from northern California who had electronic BMI data available
2 BMI categories based on categories reported in clinical databases.
Table 6: Self-reported demographic, body mass index, and prostate cancer screening data in the CMHS Cohort compared to 
California Health Interview Survey* (CHIS), males aged 50 to 64 years.
CMHS % CHIS %
Race/Ethnicity
White 63.3 63.9
Black/African-American 7.4 5.6
Latino 12.9 17.5
Asian 7.3 9.9
Other 8.9 3.1
Education
BA/BS degree 48.6 43.0
Birthplace
Foreign born 20.1 25.1
Marital Status
Married 77.1 73.6
Single, never married 5.8 6.5
Other (widowed, separated, divorced, living with partner) 16.8 19.9
Body Mass Index
0–18.49 0.6 0.6
18.5–24.99 25.2 28.0
25.0–29.99 46.8 48.0
30.0 or higher 27.2 23.4
PSA test ever 57.6 44.0
* Based on data from the California Health Interview Survey. Copyright © 2003 The Regents of the University of California. All Rights Reserved.BMC Public Health 2006, 6:172 http://www.biomedcentral.com/1471-2458/6/172
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The relatively low recruitment rates raise the issue of gen-
eralizability of the study findings to the broader commu-
nity, although this aspect of this study is within the range
that is found in other general cohort recruitment efforts.
Prospective cohorts are considered valuable partly
because well conducted and followed cohorts allow inter-
nally valid comparisons to be made [18-21], similar to
clinical trials which are considered to be internally valid
despite inclusion of typically highly selected participants
[22]. No cohort is strictly generalizable to the population
as a whole. Rather, research from some of the most widely
cited cohorts is derived from study populations that are
overwhelmingly from one race/ethnic group [23-30],
occupational group or class group [23,24,26,27], or
observational studies following clinical trials [31, 32, 33].
Nonetheless, the CMHS cohort was similar to the popula-
tion of health plan members on important characteristics
and appeared similar to men who responded a general
health survey in California on a variety of important
demographic and clinical characteristics. Thus, a cohort
such as this one should be able to address biologically rel-
evant questions related to disease onset and progression.
A wide variety of epidemiologic, health services, and out-
comes research is possible within this multiethnic cohort.
The cohort is available for study by non-Kaiser Perma-
nente investigators and students conditional upon
approval by the CMHS Proposal Review Committee. A
rich array of electronic, biological, and clinical resources is
available to supplement and enhance the survey data and
to facilitate the study of outcomes other than cancer while
controlling for major health risk factors. The large pro-
spective cohorts in the United States have made enormous
contributions to our knowledge of the causes of cancer
and other diseases, and we believe the CMHS is poised to
make important contributions in the area of men's health.
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